Toxoplasma infection in schizophrenia patients: A comparative study with control group

Iranian Journal of Parasitology

Volumn 6, Issue 2, 2011, Pages 31-37

  Alipour, A ^a   Shojaee, S ^a   Mohebali, M ^a   Tehranidoost, M ^b   Abdi Masoleh, F ^b   Keshavarz, H ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ELISA; Iran; Schizophrenia; Toxoplasma gondii

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; SCHIZOPHRENIA; SEROLOGY; SEROPREVALENCE; TOXOPLASMOSIS;

TOXOPLASMA; TOXOPLASMA GONDII;

EID: 79959403079     PISSN: 17357020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Dubey JP. Toxoplasmosis of Animals and Humans. Second edition. CRC Press; 2010, 313.
2. Carruthers VB, Suzuki Y. Effect of Toxoplasma gondii Infection on the Brain. SchizopherBull. 2007:33:745-51.
3. Wang HL, Wang GH, Liq Y, Shu C, Jiang MS, Guo Y. Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma seropositive and Toxoplasma seronegative schizophrenia. Acta PsychiatrScand. 2006:40-8.
4. Flegr J, Zitkova S, Kodym P, Frynta D. Induction of changes in human behavior by the parasitic protozoan Toxoplasma gondii.Parasitol. 1996;113:49-54.
5. Flegr J, Kodym P, Tolarova V. Correlation of duration of latent Toxoplasma gondii infection with personality changes inwomen. BiolPsychol.2000;53:57-68.
6. Holliman RE. Toxoplasmosis, behavior, and personality.J Infect.1997;35:105-10.
7. Havlicek J, Gasova Z, Smith AP, Zvara K, Flegr J. Decrease of psychomotor performance in subjects with latent asymptomatic tox-oplasmosis. Parasitol. 2001;122:515-20.
8. Torrey EF, Yolken RH. Could schizophrenia be a viral zoonosis transmitted from house cat? Schizophr Bull. 1995; 21:167-71.
9. Brown AS, Schaefer CA, Quesenberry CP, Liu L, Babulas VP, Susser ES. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. AmJ Psychiatry. 2005;162:767-73.
10. Torrey EF, Rawlings R, Yolken RH. The antecedents of psychoses: a case-control study of selected risk factors. Schizophr Res.2000;46:17-23.
11. Delgado GG, Garcia LJ. Reactivity of the intradermal test with toxoplasmosis in schizophrenic patients. Rev CubanaMed Trop. 1979;31:225-31.
12. Li QY, Luo XN, Li L, Tong F. Comparative study on Toxoplasma infection in patients with schizophrenia and affective disorder. Med J Wuhan Univ (Chinese). 1999;20:222-3.
13. Gu H, Yolken RH, Phillips M et al. Evidence of Toxoplasma gondii infection in recent-onset schizophrenia (abstract). Schizophr Res.2001;49:53.
14. Yolken RH, Bachmann S, Rouslanova I et al. Antibodies to Toxoplasma gondii in ind-ividuals with first-episode schizophrenia. Clin InfectDis. 2001;32:842-44.
15. Leweke FM, Gerth CW, Koethe D et al. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2004;254:4-8.
16. Jones-Brando L, Torrey EF, Yolken R. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res.2003.62 (3),237-44.
17. Torrey EF, Yolken RH. Toxoplasma gondii and Schizophrenia. Emerg Infect Dis. 2003;9:1375-80.
18. Cetinkaya Z, Yazar S, Gecici O, Namli MN. Anti-Toxoplasma gondii antibodiesin patients with schizophrenia-preliminary fin-dings in a Turkish sample. Schizophr Bull. Advance Access April2, 2007.
19. Johnstone A, Thorpe R. Immunochemistry in practice. 3rd ed. London: Blackwell Science;1996.
20. Johnson JD, Holliman RE. Toxoplasmosis. In: Gillespie SH. Hawkey PM(Eds). Medical Parasitology practical approach. 1st ed. New york: Oxford university press;1995.
21. Powell HC, Gibbs CJ Jr, Lorenzo AM, Lampert PW, Gajdusek DC. Toxoplasmosis of the central nervous system in the adult. Electron microscopic observations. Acta Neuropathol (Berl). 1978;41:211-6.
22. Bertoli F, Espino M, Arosemena JR, Fishback JL, Frenkel JK. A spectrum in the pathology of toxoplasmosis in patients with acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1995;119:214-24.
23. Ghatak NR, Zimmerman HM. Fine structure of Toxoplasma in the human brain. Arch Pathol. 1973;95:276-83.
24. Cotter DR, Pariante CM, Everall IP. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull.2001;55:585-95.
25. Doyle C, Deakin JFW. Fewer astrocytes in frontal cortex in schizophrenia, depression and bipolar disorder [abstract]. Schizophr Res.2002;53:106.
26. Sims TS, Hay J. Host-parasite relationship between congenital Toxoplasma infection and mouse brain: role of small vessels. Parasitology. 1995;110:123-7.
27. Torrey EF, Bartko JJ, Lun ZR, Yolken RH. Antibodies to Toxoplasma gondii in patients with schizophrenia: A Meta-Analysis. Schizophr Bull.2007:33:729-36.
28. Torrey EF. Are we overestimating the genetic contribution to schizophrenia? Schizo-phrBull. 1992;18:159-170.
29. Saraei-Sahnesaraei M, Shamloo F, Jahani Hashemi H, Khabbaz F, Alizadeh SA. Relation Between Toxoplasma gondii Infections and Schizophrenia. Iranian J PsychaitrClin Psychol. 2009;15 (1):3-9.
30. Boks MPM, Liddle PF, Burgerhof JGM, Knegtering R, Van den Bosch R-J. Neurological soft signs discriminating mood disorders from first episode schizophrenia. Acta Psychiatr Scand. 2004; 110:29-35.
31. Hill K, Mann L, Laws KR, Stephenson CME, Nimmo-Smith I, McKenna PJ. Hypofrontality in schizophrenia: a metaanalysis of functional imaging studies. Acta Psychiatr Scand. 2004;110:243-56.